Literature DB >> 10857172

Selective neck dissection and sentinel node biopsy in head and neck squamous cell carcinomas.

G Mamelle1.   

Abstract

The Sentinel Node concept is now well established for HNSCC and gives us a strong basis to treat patients with N0 neck where the rate of occult node metastasis is high. At the present time, the most accurate method for staging N0 neck is pathologic examination of the neck content. In this way, sentinel node dissection (SND) and sentinel node biopsy (SNB) are complementary surgical procedures. SNB has limited indications in HNSCC because of the inaccessibility of most of the primary sites to local injection of Tc99m colloid. However it seems to be an encouraging approach for small tumors of the oral cavity. In other primary sites, except for small glottic tumors, patients must undergo an SND. Supraomohyoid neck dissection which removes levels I, II and III, is performed in oral cavity tumors. Lateral neck dissection which removes levels II, III and IV, is used by many authors for laryngeal, oropharyngeal and hypopharyngeal tumors. In our experience, SND could be limited to levels II and III for laryngeal and oropharyngeal tumors without more neck failures. SND is a reliable procedure, we report only 1.5% of skip nodal metastases in 464 patients who had this staging procedure.

Entities:  

Mesh:

Year:  2000        PMID: 10857172     DOI: 10.1007/978-3-642-57151-0_16

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  4 in total

1.  Is there a role for lymphoscintigraphy and sentinel node biopsy in the management of the regional lymphatics in mucosal squamous cell carcinoma of the head and neck?

Authors:  Nicholas Hyde; Elizabeth Prvulovich
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-03-27       Impact factor: 9.236

2.  Downregulation of EphA2 expression suppresses the growth and metastasis in squamous-cell carcinoma of the head and neck in vitro and in vivo.

Authors:  Yong Liu; Changyun Yu; Yuanzheng Qiu; Donghai Huang; Xiaojuan Zhou; Xin Zhang; Yongquan Tian
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-16       Impact factor: 4.553

3.  A novel extracellular drug conjugate significantly inhibits head and neck squamous cell carcinoma.

Authors:  Larissa Sweeny; Yolanda E Hartman; Kurt R Zinn; James R Prudent; David J Marshall; Mohammed S Shekhani; Eben L Rosenthal
Journal:  Oral Oncol       Date:  2013-08-03       Impact factor: 5.337

4.  Neck dissection in squamous cell carcinoma of the tongue.

Authors:  Ali Amar; Otávio Alberto Curioni; Sergio Altino Franzi; Daniel Knabben Ortelado; Abrão Rapoport
Journal:  Braz J Otorhinolaryngol       Date:  2006-01-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.